Literature DB >> 7641906

Ovarian senescence and its significance on uterine and ovarian perfusion.

A Kurjak1, S Kupesic.   

Abstract

OBJECTIVE: To measure the flow velocity of the ovarian, uterine, radial, and spiral arteries in different age groups.
DESIGN: Serial measurements throughout the menstrual cycle in normal cycling women with documented fertility were compared with those in postmenopausal patients with and without hormone replacement therapy (HRT).
SETTING: Department of Obstetrics and Gynecology, University of Zagreb, Sveti Duh Hospital, Zagreb, Croatia. PATIENTS: Two hundred fifty patients were analyzed: 120 healthy fertile women, 85 postmenopausal patients, and 45 postmenopausal patients receiving HRT.
INTERVENTIONS: All patients were examined by transvaginal color and pulsed Doppler. MAIN OUTCOME MEASURE: Changes in the resistance index of flow velocity waveforms of the ovarian, uterine, radial, and spiral arteries.
RESULTS: Ovarian artery Doppler measurements in postmenopausal patients showed a significant difference when compared with the ovarian artery on the side containing dominant follicle or corpus luteum in healthy fertile group. Uterine and radial artery flow velocity analyses demonstrated significant positive correlations between the resistance index and years of menopause. In patients receiving HRT, a lowering effect occurred in the resistance index of the main uterine artery and its intramyometrial branches. Visualization of clear Doppler signals from the spiral arteries was possible in 30% of women who were menopausal for < 5 years. Increased vascular impedance was the typical finding in this vessel for this group of patients. The addition of HRT resulted in higher visualization rates of the spiral arteries and lowered resistance index values.
CONCLUSIONS: There are changes in the flow velocity patterns of the ovarian, uterine, radial, and spiral arteries with age. The fact that the uterine artery resistance index does not change significantly in the first postmenopausal years strongly supports the thesis that the aging process initially affects the uterus less than the ovary. Furthermore, the uterine environment can be manipulated more easily during the menopausal years by proper hormonal stimulation.

Entities:  

Mesh:

Year:  1995        PMID: 7641906     DOI: 10.1016/s0015-0282(16)57788-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Development of Asherman syndrome after conservative surgical management of intractable postpartum hemorrhage.

Authors:  Ciaran A Goojha; Allison Case; Roger Pierson
Journal:  Fertil Steril       Date:  2010-03-26       Impact factor: 7.329

2.  Racial and regional differences in age at menopause in the United States: findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Katherine K McKnight; Melissa F Wellons; Cynthia K Sites; David L Roth; Jeff M Szychowski; Jewell H Halanych; Mary Cushman; Monika M Safford
Journal:  Am J Obstet Gynecol       Date:  2011-05-14       Impact factor: 8.661

3.  Role of spiral artery Doppler to screen type 2 endometrial cancer cases.

Authors:  Soner Düzgüner; Mehmet Burak Ozkan; Tuncay Küçüközkan; Enis Ozkaya; Fadıl Kara; Ipek Nur Balın; Vakkas Korkmaz; Mehmet Fatih Karslı; Burak Gültekin
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-03-01

4.  Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.

Authors:  Irit Ben-Aharon; Tal Granot; Israel Meizner; Noa Hasky; Ana Tobar; Shulamith Rizel; Rinat Yerushalmi; Avi Ben-Haroush; Benjamin Fisch; Salomon M Stemmer
Journal:  Oncologist       Date:  2015-06-22

5.  Prediction of pregnancy rate of in vitro fertilization and embryo transfer in women aged 40 and over with basal uterine artery pulsatility index.

Authors:  C H Chiang; T T Hsieh; M Y Chang; C S Shiau; H C Hou; J J Hsu; Y K Soong
Journal:  J Assist Reprod Genet       Date:  2000-09       Impact factor: 3.412

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.